' INTRODUCTION
After their first discovery in 1976, sigma (σ) receptor research met a renovated enthusiasm in the early 1990s when the two subtypes, σ 1 and σ 2 , were identified. 1 The σ 1 subtype was soon thereafter isolated and cloned from different sources, 2 and it has been recently classified as a receptor chaperone at the endoplasmic reticulum (ER) membrane that regulates ER-mitochondrial Ca 2+ signaling and cell survival. 3 Although their mechanism of action is still unclear, σ proteins receive much interest because of their potential applications as drug targets for a wide range of diseases. σ 1 receptor ligands display neuroprotective and neuroregulative functions and are under evaluation for the treatment of a number of neurological disorders 4 such as depression, 5 schizophrenia, 6 Alzheimer's and Parkinson's diseases, 7À9 and for drug abuse (e.g., cocaine). 10 The high therapeutic potential of σ 2 receptors comes from the evidence that this subtype is overexpressed in a wide variety of cancer tissues, and activation of σ 2 receptors lead tumor cells to death through different apoptotic pathways. 11À13 Therefore, a number of σ 2 receptor ligands are under investigation for cancer treatment and diagnosis. 14À16 Nevertheless, the σ 2 subtype is not as well as characterized as the σ 1 . It has not yet been cloned, and attempted characterization from homogenate of σ 2 -overexpressing tumor cells led to isolation of histone proteins by affinity chromatography. 17 The σ 2 selector used was a derivative of 1-cyclohexyl-4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)-n-propyl]piperazine (1, PB28), one of the highest affinity σ 2 receptor ligands known, 18, 19 concluding that either σ 2 receptors may be histones or histone binding proteins or compound 1 binds such proteins as well as σ 2 receptors, with modeling studies conducted to rationalize these hypotheses. 20 Such results were in disagreement with findings from fluorescence microscopy, which localizes σ 2 subtypes in several organelles except the nucleus through the use of fluorescent σ 2 ligands. 21, 22 Besides the intracellular localization, there are other ambiguities related to the σ 2 receptors: evidence shows that σ 2 ligands activate different apoptotic pathways in diverse tumor cells. 11À13,23 With the aim of helping to clarify some of these ambiguities, we synthesized a small series of fluorescent derivatives of compound 1 to be used in microscopy studies for the purpose of localizing σ 2 receptors subcellularly within cancer cells.
Intrinsically fluorescent compound 1 analogues have been synthesized in the past, with appreciable σ receptor affinity but with maximum excitation and emission wavelength (λ exc and λ em ) inappropriate for use in living cells for fluorescence Received: May 11, 2011 ABSTRACT: Fluorescent derivatives of σ 2 high affinity ligand 1-cyclohexyl-4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]piperazine 1 (PB28) were synthesized. NBD or dansyl fluorescent tags were connected through a 5-or 6-atom linker in two diverse positions of 1 structure. Good σ 2 affinities were obtained when the fluorescent tag was linked to 5-methoxytetralin nucleus replacing the methyl function. NBD-bearing compound 16 displayed high σ 2 affinity (K i = 10.8 nM) and optimal fluorescent properties. Its uptake in pancreatic tumor cells was evaluated by flow cytometry, showing that it partially occurs through endocytosis. In proliferating cells, the uptake was higher supporting that σ 2 receptors are markers of cell proliferation and that the higher the proliferation is, the stronger the antiproliferative effect of σ 2 agonists is. Colocalization of 16 with subcellular organelles was studied by confocal microscopy: the greatest was in endoplasmic reticulum and lysosomes. Fluorescent σ 2 ligands show their potential in clarifying the mechanisms of action of σ 2 receptors. microscopy. 24 Therefore, we followed a common approach to overcome this limitation: dansyl (λ exc ∼315 nm) and 7-nitro-2,1,3-benzoxadiazole (NBD) (λ exc ∼420 nm) moieties were alternatively inserted in two different positions on compound 1 structure through a 5-or 6-atom linker. Such separation between the pharmacophore and the fluorescent tag should prevent the loss of affinity, leaving the fluorescent properties of the fluorescent moieties almost unchanged. Compound 16, with the best fluorescence/pharmacological properties, was used for preliminary fluorescence microscopy analyses in murine and human pancreatic tumor cells which have been previously shown to overexpress σ 2 receptors. 11 Human pancreatic tumor cells (BxPC3) were selected for more extensive studies of compound 16, whose internalization and colocalization by confocal microscopy with subcellular organelles were evaluated.
' RESULTS AND DISCUSSION Chemistry. The synthetic pathways for final compounds 7, 8, and 16À19 are depicted in Schemes 1 and 2. Key intermediate 6 was prepared starting from commercial piperidin-4-one ethylene ketal (1,4-dioxa-8-aza-spiro[4.5]decane), which was alkylated with 6-bromohexanenitrile, affording intermediate 2. Upon reduction with LiAlH 4 to the corresponding amine and subsequent amine protection through acetylation, compound 2 provided derivative 3. Acidic deprotection of the ethyleneÀacetal function with HCl led to intermediate 4, which underwent reductive amination with piperazine 5, 25 providing the acetyl derivative of 6, which was deacetylated, affording key amine 6. Reaction of this latter alternatively with NBD-chloride or dansyl chloride afforded the fluorescent compounds 7 and 8, respectively (Scheme 1).
The final compounds 16À19 were synthesized as outlined in Scheme 2. The reaction between potassium phthalimide and 1,6-dibromohexane gave intermediate Table 1 . The introduction of the fluorescent tag and the linker produced a decrease in the affinity at both σ receptors with respect to lead compound 1. The most dramatic drop in the affinity at both σ receptors was observed with compounds 7 (K i = 2570 nM for σ 1 and K i = 1720 nM for σ 2 receptor) and 8 (K i > 5000 nM for σ 1 and K i = 5020 nM for σ 2 receptor), which reached micromolar values. In such compounds, the piperidine ring replacing the cyclohexyl ring was functionalized with the fluorescent tag through a six-methylene chain. The drop in the affinity was independent from the nature of the fluorescent tag, indicating that functionalization (at least with a six-atom linker) in that position of the pharmacophore was not tolerated by the σ 2 receptors, in accordance with a previous study in which substitution of the cyclohexyl with more hindered substituents led to reduced σ affinities. 18, 27 On the other hand, fluorescent final compounds obtained through insertion of the alkyl fluorescent tag on the 5-methoxy-tetralin ring in place of the methyl group displayed nanomolar affinities at both σ receptors (compounds 16À19). Previous SAfiR studies demonstrated how the methoxy substituent was unessential for σ 2 receptor binding indeed. 28 NBD or dansyl moieties were tolerated at the σ 2 receptor, with the highest affinity displayed by the NBD-bearing compound 16 (K i = 10.8 nM). The presence of the NBD, but not of the dansyl moiety, appeared to be detrimental (K i = 78.8 nM for 16 and K i = 96.2 nM for 17) for σ 1 receptor binding. With σ 1 and σ 2 affinities in the same range, dansyl-bearing ligands 18 and 19 did not show any σ 2 versus σ 1 selectivity, whereas compounds bearing NBD (16 and 17) displayed a moderate σ 2 selectivity (8-fold and 2.5-fold, respectively). Selectivity was missing in lead compound 1 when binding assays were performed on animal tissues according to literature protocols. 18 Results obtained with this small series of compounds demonstrated that a fluorescent tag spaced out from the tetralinoxy moiety by a 5-or 6-atom linker leads to molecules with good σ receptor affinities useful for in living cells visualization of σ 2 receptors, with compound 16 displaying the best pharmacological properties for further investigation.
Fluorescent Ligand Studies. The fluorescent properties of final compounds are listed in Journal of Medicinal Chemistry ARTICLE spectra were obtained from solution of the final compounds in organic solvents (EtOH and CHCl 3 ) and in aqueous solution (PBS buffer). The NBD-bearing compounds (8, 16, 17) displayed excitation peaks at two different wavelengths (∼335 and ∼450 nm), and for both the wavelengths, the corresponding λ em was ∼520 nm. The λ exc selected to perform the assays in living cells was 450 nm to avoid cells autofluorescence phenomena. Dansyl-bearing compounds (7, 18, 19 ) displayed a λ exc more shifted toward the UV region (∼340 nm). All of the compounds showed an important difference between λ exc and λ em (Stokes shift). Quantum yields (Φ) were determined in the abovementioned solvents to probe the environment affecting the sensitivity of the final fluorescent ligands because the fluorophores selected (Dansyl and NBD) are endowed with environment sensitivity properties, (i.e., low quantum yield in aqueous solution but high fluorescence in nonpolar solvents or when bound to a hydrophobic sites). All tested compounds exhibited very low fluorescence in PBS buffer but became fluorescent in the organic solvents. The highest quantum yields were those recorded in CHCl 3 for all the final compounds: Φ values were 2-or 4-fold higher in CHCl 3 than in EtOH for NBD-bearing compounds (8, 16, 17) and several-fold higher than in PBS buffer. Dansylbearing compounds (7, 18, 19) showed a less pronounced increase in Φ values from EtOH to CHCl 3 solutions, although the highest Φ was shown by compound 19 (Φ = 0.48). Molar extinction coefficients (ε) were determined for all final compounds (in EtOH), with the lowest values displayed by the dansyl-bearing compounds (2600À4000 L/mol 3 cm) and the highest values displayed by the NBD-bearing compounds (6544À14391 L/mol 3 cm), indicating that the fluorescence intensity of the latter compounds is stronger. Preliminary fluorescence microscopy experiments were conducted with compound 16, which displayed the best combination between pharmacological (σ 2 receptor affinity and selectivity) and fluorescence properties (convenient excitation and emission wavelengths and high ε value), and promising results were obtained in different tumor pancreatic cells which were previously shown to overexpress σ 2 receptors.
11 Therefore, compound 16 was evaluated in more details in in vitro internalization studies and cellular colocalization by confocal microscopy in human pancreatic tumor cells (BxPC3).
In Vitro Internalization Studies. Uptake of compound 16 in BxPC3 pancreatic cancer cells was analyzed immediately following treatment (25 nM) and the mean fluorescence recorded over time ( Figure 1A ). The T 1/2 of maximum fluorescence at 60 min was 7.8 ( 1.5 min (mean ( SEM). We further studied uptake for the purpose of better understanding the involvement of endocytosis of these compounds and the receptor. Caveolin-mediated (lipid rafts-mediated) endocytotis can be inhibited by Filipin III 29 and clathrin-mediated endocytosis by phenylarsine oxide (PAO). 30 BxPC3 cells were pretreated with Filipin III (5 μg/mL) or PAO (10 mM) for 30 min prior to treatment with compound 16 (25 nM) and mean fluorescence was collected over 60 min. The rate of uptake was decreased from 7.8 ( 1.5 min to 6.8 ( 0.8 min for Filipin III and 4.9 ( 2.1 min for PAO. As well, the overall uptake at 60 min was decreased to 69% and 50% for Filipin III and PAO, respectively. Taken together, the T 1/2 in the range of minutes, and the decreased uptake in the presence of endocytosis inhibitors suggest that the internalization of 16 occurs, in part, through the caveolin-and clathrin-mediated endocytotic pathways in addition to simple membrane diffusion. Uptake by the clathrin-dependent pathway has been described previously with other σ 2 receptor ligands, 21, 22 but uptake by the caveolin- b Fluorescence properties herein reported were evaluated on compounds as free bases, but they were also evaluated on their corresponding hydrochloride salts in EtOH and PBS solutions. A maximum of 5 nm shift was observed in the excitation and emission wavelengths when compared to the excitation and emission wavelengths from the corresponding free bases.
c All compounds solubilized in PBS gave Φ value very close to 0 and therefore they are not reported.
d From EtOH solutions of compounds in EtOH.
e From ref 18 , where results from binding on human cells, in which compound 1 displays about 40-fold σ 2 versus σ 1 selectivity, are also reported.
f From a unique experiment.
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ARTICLE dependent/lipid raft pathway has not been previously reported. Interaction and endocytosis of compound 16 through lipid rafts is of note considering that σ 2 receptor agonists were initially found to bind to protein constituents of the lipid rafts, 31, 32 cholesterol-rich domains in the cell membrane. They form flask-shaped invaginations called caveolae, for the caveolin protein that coats them, and act as platforms for glycophosphatidylinositol-linked protein mediated signaling pathways and internalization of cholesterol. 33 Interest has grown in targeting this pathway in cancer cells, which may have disrupted lipid rafts, contributing to aberrances in pathways implicated in chemoresistance such as the epidermal growth factor receptor and tumor necrosis factor R receptor. 34 Therefore, implication of lipid raft disruption in oncology signaling and response to chemotherapy together with the presence of σ 2 proteins in lipid rafts suggest that σ 2 receptor mediated toxicity and overcame chemoresistance (which has been shown with different σ 2 receptor agonists), 23, 35 likely involve lipid rafts.
In vitro competition was performed to quantify interaction of compound 16 with σ 2 agonists in the live cell. Preloading with 1 or the recently produced σ 2 agonist cis-1-cyclohexyl-4-[4-(2,6-difluorophenyl)cyclohexyl]piperazine 36 (20) for 45 min prior to addition of compound 16 for 45 min decreased the mean fluorescence intensity of 16 with increasing concentrations of σ 2 agonist ( Figure 1B ). This indicates that the fluorescent compound functionally competes for localization in the same plane as the parent and analogue compound.
The correlation between the proliferative status of tumors and the expression of the σ 2 receptors has been widely demonstrated in different cancer cell lines, 22, 37, 38 and we have further detailed the expression and apoptosis response in pancreatic cancer cells. 11, 39 In this study, we further evaluated the impact of proliferation on σ 2 agonist uptake and sensitivity ( Figure 1C ). To maintain proliferating versus quiescent cell cultures, subcultured cells were seeded at increasing densities in order to achieve subconfluent and confluent cultures, respectively. Compound 16 mean fluorescence at 30 min decreased as cell density increased, in accordance with earlier findings that σ 2 receptors are markers of cell proliferation. 40 In addition, the decreased uptake was associated with decreased cell death as the density increased so that the reduction of the antiproliferative activity of σ 2 agonists 1 and 20 was likely due to the σ 2 reduced presence in nonproliferating cells. Together, these findings show that compound 16 performs biologically as expected for a σ 2 ligand and that increased uptake of σ 2 agonists by proliferating cells is a critical step for mediating cell death.
Cellular colocalization studies of these fluorescent analogues of 1 were initially screened by epifluorescent microscopy (Supporting Information), and confocal microscopy results were in accordance with those findings (Figure 2 ). BxPC3 cells were incubated with fluorescent ligand 16 and MitoTracker Red, 
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ERTracker Red, LysoTracker Red, or Vybrant cholera-toxin B subunit (CT-B), at 37°C for 30 min prior to fixation and nuclear staining with TO-PRO-3. Compound 16 is found in the membrane fractions of the cell and colocalizes greatest in the endoplasmic reticulum and lysosomes, with moderate colocalization in the mitochondria and the plasma membrane (CT-B). Colocalization in the nucleus was not observed with TO-PRO-3.
' CONCLUSIONS
Fluorescent σ 2 ligands were obtained linking dansyl or NBD moieties in two different positions of compound 1 structure. High affinity σ 2 ligands were obtained when the fluorescent tag was attached on the tetralin ring through an alkyl linker replacing the methyl in the methoxy function. On the other hand, the approach of attaching a fluorescent tag at the compound 1 cyclohexyl moiety (replaced by a piperidine ring) was unsuccessful, and a dramatic drop in the affinity was recorded. NBDbearing compounds displayed better fluorescent properties (more convenient λ exc and λ em and high fluorescence intensity) than dansyl-bearing compounds, and among them, compound 16 displayed high σ 2 receptor affinity and moderate σ 1 /σ 2 selectivity. Therefore, compound 16 internalization was studied by flow cytometry and by confocal microscopy for colocalization with subcellular organelles in BxPC3 pancreatic tumor cells. The uptake of fluorescent ligand 16 decreased in the presence of nonfluorescent σ 2 ligands, showing that fluorescent and nonfluorescent compounds compete for localization in the same plane. Endocytosis inhibitors decreased the uptake of compound 16, showing that internalization occurs, in part, through endocytotic pathways besides simple membrane diffusion, and that interaction with lipid rafts, which may be able to influence the membrane composition and downstream signaling, takes place so that σ 2 receptor mediated toxicity and chemoresistance overcome likely involve lipid rafts. The influence of proliferation, with cell density as a surrogate, on σ 2 agonist uptake and sensitivity, was studied and showed that the uptake is higher in proliferating cells, supporting that σ 2 receptors are markers of cell proliferation. 37, 38 Furthermore, the sensitivity of BxPC3 cells for σ 2 agonists decreased, together with the uptake, as the density (i.e., quiescent cells) increased, suggesting that uptake is a critical step for mediating σ 2 agonists-dependent cell death. Compound 16 colocalized to the greatest extent in the endoplasmic reticulum and lysosomes, with moderate colocalization in the mitochondria and the plasma membrane but no colocalization in the nucleus was observed, in disagreement with the histone hypothesis which will have to be further analyzed.
All in all, it was demonstrated that the use of fluorescent σ 2 ligands may help in clarifying the mechanisms of action of the still enigmatic σ 2 receptors. The use of such compounds in different cell lines may contribute to understand the different cell type apoptotic pathways activated by σ 2 ligands. Furthermore, a scaffold which appears optimal for inferring high σ receptor affinities was herein produced, and it can be further exploited for obtaining fluorescent molecules with λ exc and λ em more shifted toward the near-infrared (NIR) region of the spectrum for a wider application of σ receptor fluorescent ligands in optical molecular imaging techniques.
' MATERIALS AND METHODS
Chemistry. Both column chromatography and flash column chromatography were performed with 60 Å pore size silica gel as the stationary phase (1:30 w/w, 63À200 μm particle size, from ICN, and 1:15 w/w, 15À40 μm particle size, from Merck, respectively). Melting points were determined in open capillaries on a Gallenkamp electrothermal apparatus. Purity of tested compounds was established by combustion analysis, confirming a purity g95%. Elemental analyses (C, H, N) were performed on an Eurovector Euro EA 3000 analyzer; the analytical results were within (0.4% of the theoretical values unless otherwise indicated.
1 H NMR spectra were recorded on a Mercury Varian 300 MHz using CDCl 3 as solvent. The following data were reported: chemical shift (δ) in ppm, multiplicity (s = singlet, d = doublet, t = triplet, m = multiplet), integration, and coupling constant(s) in hertz. Recording of mass spectra was done on an Agilent 6890À5973 MSD gas chromatograph/mass spectrometer and on an Agilent 1100 series LC-MSD trap system VL mass spectrometer; only significant m/z peaks, with their percentage of relative intensity in parentheses, are reported. Chemicals were from Aldrich and Across and were used without any further purification. BxPC3 pancreatic cancer cells were incubated with 16 and subcellular markers, as described in the Materials and Methods, and imaged by confocal microscopy. 16 is presented as green, organelle markers in red, and overlays in yellow.
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The reaction mixture was washed with H 2 O, and the separated organic layer was concentrated under reduced pressure to give a crude mixture, which was purified by column chromatography with CH 2 Cl 2 /MeOH (95:5) as eluent, to afford the target compound as a pale-yellow oil (1.16 g, 87% yield). 1 
N-[6-(4-Oxopiperidino)hexyl]acetamide (4).
To a solution of amide 3 (0.32 g, 1.13 mmol) in acetone, 2 N HCl (37 mL) was added and the mixture was heated at reflux for 1 h followed by 1 h at room temperature. The solvent was removed under reduced pressure, and conc NaOH was added to obtain an alkaline pH. The aqueous phase was extracted with AcOEt (3 Â 15 mL), and the organic layers collected and dried (Na 2 SO 4 ) and evaporated under reduced pressure to afford the target compound as a yellow oil (0.17 g, 63% yield), which was used for the next step without further purification. 44 mmol) was refluxed in 3N HCl (6.5 mL) for 4 h. After cooling, the mixture was made alkaline with K 2 CO 3 (satd solution, 10 mL) and extracted with CH 2 Cl 2 (3 Â 10 mL). The collected organic layers were dried (Na 2 SO 4 ), and the solvent was evaporated to produce a brown semisolid (0.20 g, 99% yield), which was used for the next step without any further purification. (11) . A grain of NaI, K 2 CO 3 (0.14 g, 1.0 mmol), and phthalimide 9 (0.29 g, 1.0 mmol) were added to a solution of phenol 10 (0.26 g, 0.74 mmol) in DMF (5 mL), and the reaction mixture was heated at 100°C for 18 h. After cooling, the solvent was removed under reduced pressure, and then H 2 O (5 mL) was added to the residue and the mixture was extracted with AcOEt (3 Â 10 mL). The crude was purified by flash chromatography with ethyl acetate/CH 2 Cl 2 (6:4) as eluent to give compound 11 as a yellow oil (0.094 g, 16% yield). 1 12). To a solution of phenol 10 (0.14 g, 0.4 mmol) in DMF (5 mL), a grain of NaI, K 2 CO 3 (0.06 g, 0.5 mmol), and 2-(2-chloroethoxy)ethanol (0.05 mL, 0.5 mmol) were added, and the reaction mixture was heated at 120°C for 18 h. After cooling, the solvent was evaporated under reduced pressure, and then water was added to the residue. The mixture was extracted with AcOEt (3 Â 5 mL), and the collected organic layers collected were dried (Na 2 SO 4 ) and evaporated to afford a crude, which was purified by flash chromathography with AcOEt/CH 2 Cl 2 (7:3) as eluent to give the target compound 12 as a yellow oil (0.11 g, 62% yield). 1 (13) . To a stirred solution of alcohol 12 (0.12 g, 0.27 mmol) in dry THF (10 mL) kept under N 2 , triphenylphosphine (0.12 g, 0.46 mmol), phthalimide (0.069 g, 0.47 mmol), and DIAD (0.12 mL, 0.60 mmol) were added, and the mixture was stirred at room temperature for 18 h. Then the solvent was evaporated under reduced pressure, and the resulting residue was treated with H 2 O and the aqueous layer was extracted with AcOEt (3 Â 20 mL). The combined organic layers were dried (Na 2 SO 4 ) and concentrated under reduced pressure to give a crude residue, which was purified by column chromatography using CH 2 (15) . Hydrazine hydrate 50% (0.085 mL, 0.85 mmol) was added to a solution of either 11 or 13 (0.29 mmol) in methanol (3 mL), and the reaction mixture was stirred at room temperature for 30 min. Then 1.5 N HCl (1.2 mL) was then added, and the mixture was stirred for further 12 h. Then 3 N HCl was added until a pH < 2 was obtained, and the mixture was heated at reflux for 30 min After cooling down to room temperature, the mixture was filtered, the solid residue was washed with cold MeOH and with Et 2 O, and dried under vacuum. The white solid obtained was made free base with alkaline treatment to afford the target compound as a pale-yellow oil (70% yield). N-(7-nitro-2,1,3-benzoxadiazol-4-yl) hexanamine (7). The crude semisolid was purified by column chromatography with AcOEt/MeOH (7:3) as eluent to give the final compound 7 as an orange semisolid (0.26 g, 42% yield). General Procedure for the Synthesis of Final Compounds 8, 18, 19 . A solution of 5-(dimethylamino)naphthalene-1-sulfonyl chloride (dansyl chloride) (0.21 g, 0.8 mmol) in anhydrous CH 2 Cl 2 (15 mL) was added in a dropwise manner to one among amines 6, 14, or 15 (1.0 mmol) dissolved in the same solvent (15 mL). The mixture was stirred at room temperature for 18 h. Then, the reaction mixture was washed with H 2 O (2 Â 30 mL) and the organic phases were collected, dried (Na 2 SO 4 ), and evaporated under reduced pressure to afford a crude residue, which was purified as described below. Fluorescence Spectroscopy and Molar Extinction Coefficient. Emission spectra of compounds 7, 8, and 16À19 were determined in EtOH, CHCl 3 , and in PBS buffer solution. In all experiments, the excitation and the emission bandpass was set at 10 nm. The emission spectra were obtained from 300 to 700 nm, with excitation set at the appropriate excitation wavelength. The excitation spectra of compounds 8, 18, and 19 were obtained from 250 to 450 nm, with the emission being recorded at the appropriate wavelength. The excitation spectra of compounds 7, 16, and 17 were obtained from 300 to 550 nm, with the emission being recorded at the appropriate wavelength. Fluorescence quantum yields were calculated with respect to quinine sulfate (Fluka) in 0.5 M H 2 SO 4 as a standard (Φ = 0.546). 41 Solutions of both the sample and the reference were prepared from original solutions diluted with the appropriate solvent so that absorbance was below 0.2 at the same excitation wavelength (347 nm). Fluorescence measurements were carried out for each solution with the same instrument parameters, and the fluorescence spectra were corrected for instrumental response before integration. The quantum yield for each sample was calculated according the following equation:
2-[
where Φ is the emission quantum yield, A is the absorbance at the excitation wavelength, F is the area under the corrected emission curve, n is the refractive index of the solvent for the sample (X) and the standard (S). Absorption spectra were recorded with a PerkinElmer UVÀvis-NIR spectrophotometer, and fluorescence spectra were obtained with a PerkinElmer LS55 spectrofluorometer. Molar extinction coefficients (ε) were determined for each final compound (7, 8, 16À19 ) dissolved in EtOH, with concentration ranging from 1 to 100 μM and absorbance spectra recorded from 200 to 600 nm in standard quartz cuvettes. Biological Methods and Materials. Radioligand Binding Assays. All the procedures for the binding assays were previously described. σ 1 And σ 2 receptor binding were carried out according to Matsumoto et al. 43 ]-DTG in the presence of 1 μM (+)-pentazocine to mask σ 1 receptors, rat liver membranes. The following compounds were used to define the specific binding reported in parentheses: (a) (+)-pentazocine (73À87%), (b) DTG (85À96%). Concentrations required to inhibit 50% of radioligand specific binding (IC 50 ) were determined by using sixÀnine different concentrations of the drug studied in two or three experiments with samples in duplicate. Scatchard parameters (K d and B max ) and apparent inhibition constants (K i ) values were determined by nonlinear curve fitting by using the Prism, version 3.0, GraphPad software. 44 Cell Culture. BxPC3 pancreatic cancer cells were maintained in Roswell Park Memorial Institute (RPMI) media (GIBCO) supplemented with L-glutamine (2 mM), 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) (1 mM), pyruvate (1 mM), sodium bicarbonate (0.075% w/v), penicillin, and streptomycin (100 IU/mL), amphotericin (0.25 μg/mL), and 10% fetal bovine serum (Atlanta Biologicals, Lawrenceville, GA). Cells were seeded at a density of 2 Â 10 5 /mL unless otherwise stated and maintained in a humidified atmosphere of 5% CO 2 at 37°C.
Confocal Microscopy. For subcellular compartmentalization, cells grown on glass coverslips were incubated with compound 16 (100 nM) and either ERTracker Red (1 μM), MitoTracker Red (100 nM), or LysoTracker Red (50 nM) for 30 min at 37°C. The plasma membrane was visualized using the Vybrant Alexa Fluor 594 lipid raft labeling kit as directed by the manufacturer. All reagents were obtained from Molecular Probes. Cells were washed with PBS and fixed in 2% paraformaldehyde for 30 min at 37°C prior to additional washing and mounting to a slide with ProLong Gold antifade reagent. Imaging was performed on a Carl Zeiss Axiovert 100 inverted microscope, fitted with LSM 510 laser scanning microscope camera and software. Images were collected with filter bandwidths corresponding to 505À530 nm for green, 560À615 nm for red, and >650 nm for far red, with 4 scans over 11.8 s. ' ABBREVIATIONS USED NBD, 7-nitro-1,2,3-benzoxadiazole; ER, endoplasmic reticulum; DIAD, diisopropylazodicarboxylate; SAfiR, structureÀaffinity relationship; PBS, phosphate buffered saline; PAO, phenylarsine oxide; UV, ultraviolet; NIR, near-infrared; DMSO, dimethyl sulfoxide
